← Evidence map

ArticleNeurology(R) neuroimmunology & neuroinflammation2018

Anti-LINGO-1 has no detectable immunomodulatory effects in preclinical and phase 1 studies.

Ann Ranger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29259995